Cancer

Defence Therapeutics Aligns Accum ADC Strategy Through Multidisciplinary Scientific Advisory Board

Montreal, Quebec--(Newsfile Corp. - February 10, 2026) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"),…

16 hours ago

Medical biotech Ferronova completes enrolment for gastric and oesophageal cancer image-guided surgery trial.

ADELAIDE, Australia, Feb. 9, 2026 /PRNewswire/ -- Australian company Ferronova announced today it has completed enrolment of patients for its two-year…

20 hours ago

AMERICAN SKIN ASSOCIATION (ASA) RENEWS LONGSTANDING SPOTS PARTNERSHIP TO PROMOTE LIFELONG SKIN HEALTH EDUCATION

NEW YORK, Feb. 9, 2026 /PRNewswire/ -- American Skin Association (ASA) is pleased to renew, for the eighth consecutive year, its…

1 day ago

Lunai Bioworks, Inc. Issues Letter to Shareholders

SACRAMENTO, Calif. , Feb. 9, 2026 /PRNewswire/ -- Dear Shareholders,We have completed our AI platform in the last 12 months and…

1 day ago

TriSalus Life Sciences Appoints Veteran Healthcare Investor Michael Stansky to its Board of Directors

WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology-focused medical technology company advancing novel drug…

1 day ago

TriSalus Life Sciences Appoints Veteran Healthcare Investor Michael Stansky to its Board of Directors

WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology-focused medical technology company advancing novel drug…

1 day ago

IN8bio Promotes Kate Rochlin, Ph.D., to President and Chief Operating Officer

Photo Kate Rochlin, Ph.D., President & COO NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) -- IN8bio (Nasdaq: INAB), a clinical-stage…

1 day ago

Verrica Pharmaceuticals Announces Launch of YCANTH® for the Treatment of Molluscum Contagiosum in Japan by Partner Torii Pharmaceutical

WEST CHESTER, Pa., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing…

1 day ago

PureHealth Reports USD 550 Million Net Profit and Proposes USD 163 Million Dividend for FY 2025

USD 7.4 billion revenue and double-digit profit growth underline strength of Healthcare and Insurance across global and local markets EBITDA of…

2 days ago

AIM ImmunoTech to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial

Live video webcast on Wednesday, February 11th at 1:40 PM EST OCALA, Fla., Feb. 06, 2026 (GLOBE NEWSWIRE) -- AIM…

4 days ago